Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
contact your provider immediately if you develop severe abdominal pain
Shot: The GLP-1 Market's Next Battle The weight-loss drug market just got a lot more interesting, and a lot more competitive
Future orders can be canceled anytime through the patient portal
This offers several potential benefits: Avoids first-pass metabolism : Unlike swallowed medications that must pass through the liver, sublingual absorption delivers drugs directly to the bloodstream Bypasses stomach acid : GLP-1 peptides are degraded by digestive enzymes, so avoiding the stomach could improve stability Rich vascular network : The area under the tongue has extensive blood vessels that allow rapid absorption However, research on peptide delivery through oral mucosa reveals significant challenges: Peptides like semaglutide and tirzepatide have molecular weights around 4000 Da (compounds above 500 Da generally show poor permeability) Salivary and mucosal proteases degrade peptides before they can cross the epithelial barrier Continuous saliva production dilutes and washes away the medication Studies with insulin showed only 1-2% bioavailability via buccal/sublingual routes without absorption enhancers The key question: Do compounded ODT formulations overcome these barriers
We already have consumers ready to pay thousands of dollars to achieve their goals, so there is the real possibility to offer something valuable combining devices alongside food products or ready-made meals
Jul 1, 2026 For Licensed Providers
US$ 29.30
US$ 26.66
US$ 25.85
US$ 28.63
US$ 21.95
